Medicine and Dentistry
Patient
100%
Myocardial Infarction
64%
Therapeutic Procedure
40%
Percutaneous Coronary Intervention
39%
Fractional Flow Reserve
31%
Acute Coronary Syndrome
29%
Cardiovascular System
26%
Revascularization
25%
Follow up
19%
Hospital
17%
Mortality
17%
Death
17%
Coronary Angiography
17%
Transluminal Coronary Angioplasty
15%
Hazard Ratio
14%
Cohort Analysis
13%
Development
13%
Experience
12%
Drug Therapy
11%
Stent
10%
Cardiac Troponin
10%
Prognosis
10%
Heart Muscle Revascularization
9%
Health Care Cost
8%
Antiplatelet
8%
Heart Ventricle Remodeling
7%
Drug-Eluting Stent
7%
Observational Study
7%
Randomized Clinical Trial
7%
Diagnostic Accuracy
7%
Association
6%
Cost-Minimization Analysis
6%
Rapamycin
6%
Infarction
6%
ST Elevation
6%
Personalized Medicine
6%
Measurement
6%
Symptom
6%
Myeloid Cell
6%
COVID-19
6%
Carbohydrate Antigen
6%
Coronary Risk
6%
Left Coronary Artery
6%
Coronary Artery Recanalization
6%
Acute Coronary Syndrome
6%
Complement Inhibitor
6%
Heart Disease
6%
Electrocardiogram
5%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Infarction
68%
Beta Adrenergic Receptor Blocking Agent
12%
Acute Heart Infarction
9%
Prognosis
9%
Troponin T
6%
Coronary Artery Atherosclerosis
6%
Pharmacotherapy
6%
Elimination
6%
Emergency
5%
Unstable Angina Pectoris
5%
